John LaMattina

John L.
LaMattina is the founder of Alivio Therapeutics, Inc. Current positions include Independent Director at Ligand Pharmaceuticals, Inc. since 2011, Independent Non-Executive Director at PureTech Health LLC since 2009, Senior Independent Non-Executive Director at PureTech Health Plc since 2009, and Trustee roles at Boston College, Worcester Polytechnic Institute, and Terri Brodeur Breast Cancer Foundation.
Former roles include Chairman at Gelesis, Inc. from 2013 to 2019, Director at Neurogen Corp.
from 2008 to 2010, Director at Thermo Electron Corp.
from 2002 to 2006, Director at Human Genome Sciences, Inc. in 2012, Director at Decision Options LLC, Independent Director at Immunome, Inc. from 2017 to 2023, Director at Thermo Fisher Scientific, Inc. from 2002 to 2006, Director at Ziarco Pharma Ltd., Independent Director at Zafgen, Inc. from 2013 to 2020, Director at Vedanta Biosciences, Inc. from 2012 to 2016, President at Pfizer (St. Louis) from 2001 to 2007, and Senior Vice President-Worldwide Development at Pfizer Inc. from 1999 to 2008.
Education includes an undergraduate degree from Boston College in 1971 and a doctorate from the University of New Hampshire in 1975.